Joseph C. Wu

This is an early safety study to see if a drug called artesunate is safe and tolerable for people with Idiopathic Pulmonary Fibrosis (IPF), a serious disease that causes progressive lung scarring. About 15 participants will take the drug orally for 12 weeks at increasing doses to…

This early-stage study is testing whether heart muscle cells grown from human stem cells can be safely delivered to patients with chronic heart damage from a previous heart attack. The main goal is to find the safest dose and see if the procedure is feasible. Researchers will enr…

This early-stage study is testing whether a daily pill of artesunate, a drug used for malaria, is safe for people with pulmonary arterial hypertension (PAH). It will involve about 15 adults with PAH who are already on standard treatments. The main goal is to find a safe dose by s…